Bioequivalence Study of Olanzapine Orally Disintegrating Tablets, 5 mg Under Fed Condition
Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the single oral dose bioequivalence of olanzapine 5
mg OD tablets with Zyprexa Zydis 5 mg tablets under fed conditions and to monitor adverse
events and ensure safety of subjects.